Novavax COVID-19 Vaccine to Be Available for Priority Groups in Taiwan
Taipei: A traditional, protein-based COVID-19 vaccine developed by Novavax, targeting the JN.1 variant, will become available next Wednesday to those eligible for free vaccination, the Centers for Disease Control (CDC)